Beam Therapeutics Inc.
BEAM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $140M | $63.5M | +120% |
| Operating income | −$384M | −$416M | +7.7% |
| Net income | −$80.0M | −$377M | +78.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $300K | $9.70M | −96.9% |
| Operating income | −$141M | −$127M | −11.4% |
| Net income | −$134M | −$113M | −19.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Beam Therapeutics's revenue in FY2025?
- $140M in FY2025 (Fiscal year ended Dec 31, 2025), +120% vs $63.5M a year earlier, per its 10-K filed Feb 2026.
- Was Beam Therapeutics profitable in FY2025?
- No: net income was −$80.0M and operating income −$384M in FY2025.
- What was Beam Therapeutics's revenue in Q3 2026?
- $300K (−96.9% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.